Citadel Advisors LLC 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Citadel Advisors LLC | 511,316 1.700% | -823,557 (-61.70%) | Filing |
| 2022-10-17 4:08 pm Purchase | 2022-10-07 | 13G | Relmada Therapeutics, Inc. RLMD | Citadel Advisors LLC | 1,334,873 4.400% | 1,334,873 (New Position) | Filing |